Inspire Medical Systems, Inc. Cost of Revenue
Inspire Medical Systems, Inc. (INSP) reported Cost of Revenue of $29.12 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-03
- Inspire Medical Systems, Inc. cost of goods and services sold for the quarter ending 2026-06-30 was $29.12M, a 16.01% decline year-over-year.
- Inspire Medical Systems, Inc. cost of goods and services sold for the quarter ending 2026-03-31 was $27.67M, a 9.89% decline year-over-year.
- Inspire Medical Systems, Inc. cost of goods and services sold for the quarter ending 2025-12-31 was $36.07M, a 0.23% increase year-over-year.
- Inspire Medical Systems, Inc. cost of goods and services sold for the quarter ending 2025-09-30 was $31.77M, a 1.93% decline year-over-year.
- Inspire Medical Systems, Inc. cost of goods and services sold for fiscal 2025 was $133.22M, a 8.33% increase from fiscal 2024.
- Inspire Medical Systems, Inc. cost of goods and services sold for fiscal 2024 was $122.99M, a 27.35% increase from fiscal 2023.
- Inspire Medical Systems, Inc. cost of goods and services sold for fiscal 2023 was $96.58M, a 46.07% increase from fiscal 2022.
- Inspire Medical Systems, Inc. cost of goods and services sold for fiscal 2022 was $66.11M, a 98.67% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2026-06-30 | $29.12M 10-Q · filed 2026-08-03 | $56.79M 10-Q · filed 2026-08-03 | $92.86M derived: sum of 3 quarters · filed 2026-08-03 | $124.64M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $27.67M 10-Q · filed 2026-05-04 | $63.74M derived: sum of 2 quarters · filed 2026-05-04 | $95.52M derived: sum of 3 quarters · filed 2026-05-04 | $130.19M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $36.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $67.84M derived: sum of 2 quarters · filed 2026-02-13 | $102.52M derived: sum of 3 quarters · filed 2026-08-03 | $133.22M 10-K · filed 2026-02-13 |
| 2025-09-30 | $31.77M 10-Q · filed 2025-11-03 | $66.44M derived: sum of 2 quarters · filed 2026-08-03 | $97.15M 10-Q · filed 2025-11-03 | $133.14M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $34.67M 10-Q · filed 2026-08-03 | $65.38M 10-Q · filed 2026-08-03 | $101.37M derived: sum of 3 quarters · filed 2026-08-03 | $133.77M derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $30.71M 10-Q · filed 2026-05-04 | $66.70M derived: sum of 2 quarters · filed 2026-05-04 | $99.09M derived: sum of 3 quarters · filed 2026-05-04 | $128.94M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $35.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $68.39M derived: sum of 2 quarters · filed 2026-02-13 | $98.23M derived: sum of 3 quarters · filed 2026-02-13 | $122.99M 10-K · filed 2026-02-13 |
| 2024-09-30 | $32.40M 10-Q · filed 2025-11-03 | $62.24M derived: sum of 2 quarters · filed 2025-11-03 | $87.00M 10-Q · filed 2025-11-03 | $115.05M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $29.84M 10-Q · filed 2025-08-04 | $54.60M 10-Q · filed 2025-08-04 | $82.65M derived: sum of 3 quarters · filed 2026-02-13 | $107.04M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $24.76M 10-Q · filed 2025-05-05 | $52.81M derived: sum of 2 quarters · filed 2026-02-13 | $77.19M derived: sum of 3 quarters · filed 2026-02-13 | $101.44M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $28.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $52.44M derived: sum of 2 quarters · filed 2026-02-13 | $76.69M derived: sum of 3 quarters · filed 2026-02-13 | $96.58M 10-K · filed 2026-02-13 |
| 2023-09-30 | $24.38M 10-Q · filed 2024-11-04 | $48.63M derived: sum of 2 quarters · filed 2024-11-04 | $68.52M 10-Q · filed 2024-11-04 | $90.67M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-06-30 | $24.25M 10-Q · filed 2024-08-06 | $44.14M 10-Q · filed 2024-08-06 | $66.29M derived: sum of 3 quarters · filed 2025-02-10 | $86.08M derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-03-31 | $19.89M 10-Q · filed 2024-05-07 | $42.04M derived: sum of 2 quarters · filed 2025-02-10 | $61.83M derived: sum of 3 quarters · filed 2025-02-10 | $76.00M derived: sum of 4 quarters · filed 2025-02-10 |
| 2022-12-31 | $22.15M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | $41.94M derived: sum of 2 quarters · filed 2025-02-10 | $56.11M derived: sum of 3 quarters · filed 2025-02-10 | $66.11M 10-K · filed 2025-02-10 |
| 2022-09-30 | $19.79M 10-Q · filed 2023-11-07 | $33.96M derived: sum of 2 quarters · filed 2023-11-07 | $43.96M 10-Q · filed 2023-11-07 | $55.12M derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-06-30 | $14.17M 10-Q · filed 2023-08-01 | $24.18M 10-Q · filed 2023-08-01 | $35.33M derived: sum of 3 quarters · filed 2024-02-09 | $43.96M derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-03-31 | $10.00M 10-Q · filed 2023-05-02 | $21.16M derived: sum of 2 quarters · filed 2024-02-09 | $29.78M derived: sum of 3 quarters · filed 2024-02-09 | $37.30M derived: sum of 4 quarters · filed 2024-02-09 |
| 2021-12-31 | $11.16M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | $19.78M derived: sum of 2 quarters · filed 2024-02-09 | $27.30M derived: sum of 3 quarters · filed 2024-02-09 | $33.28M 10-K · filed 2024-02-09 |
| 2021-09-30 | $8.62M 10-Q · filed 2022-11-01 | $16.14M derived: sum of 2 quarters · filed 2022-11-01 | $22.12M 10-Q · filed 2022-11-01 | $29.28M derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-06-30 | $7.52M 10-Q · filed 2022-08-02 | $13.50M 10-Q · filed 2022-08-02 | $20.66M derived: sum of 3 quarters · filed 2023-02-10 | $25.87M derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-03-31 | $5.98M 10-Q · filed 2022-05-03 | $13.14M derived: sum of 2 quarters · filed 2023-02-10 | $18.35M derived: sum of 3 quarters · filed 2023-02-10 | $20.31M derived: sum of 4 quarters · filed 2023-02-10 |
| 2020-12-31 | $7.16M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $12.37M derived: sum of 2 quarters · filed 2023-02-10 | $14.33M derived: sum of 3 quarters · filed 2023-02-10 | $17.62M 10-K · filed 2023-02-10 |
| 2020-09-30 | $5.21M 10-Q · filed 2021-11-02 | $7.17M derived: sum of 2 quarters · filed 2021-11-02 | $10.46M 10-Q · filed 2021-11-02 | $14.70M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | $1.95M 10-Q · filed 2021-08-03 | $5.25M 10-Q · filed 2021-08-03 | $9.49M derived: sum of 3 quarters · filed 2022-02-15 | $12.95M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | $3.30M 10-Q · filed 2021-05-04 | $7.54M derived: sum of 2 quarters · filed 2022-02-15 | $10.99M derived: sum of 3 quarters · filed 2022-02-15 | $14.09M derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | $4.24M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $7.70M derived: sum of 2 quarters · filed 2022-02-15 | $10.79M derived: sum of 3 quarters · filed 2022-02-15 | $13.64M 10-K · filed 2022-02-15 |
| 2019-09-30 | $3.46M 10-Q · filed 2020-11-02 | $6.55M derived: sum of 2 quarters · filed 2020-11-02 | $9.40M 10-Q · filed 2020-11-02 | $12.60M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $3.09M 10-Q · filed 2020-08-04 | $5.95M 10-Q · filed 2020-08-04 | $9.14M derived: sum of 3 quarters · filed 2021-02-24 | $11.61M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $2.85M 10-Q · filed 2020-05-05 | $6.05M derived: sum of 2 quarters · filed 2021-02-24 | $8.51M derived: sum of 3 quarters · filed 2021-02-24 | $10.62M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $3.19M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $5.66M derived: sum of 2 quarters · filed 2021-02-24 | $7.76M derived: sum of 3 quarters · filed 2021-02-24 | $10.06M 10-K · filed 2021-02-24 |
| 2018-09-30 | $2.47M 10-Q · filed 2019-11-05 | $4.57M derived: sum of 2 quarters · filed 2019-11-05 | $6.86M 10-Q · filed 2019-11-05 | |
| 2018-06-30 | $2.10M 10-Q · filed 2019-08-06 | $4.40M 10-Q · filed 2019-08-06 | ||
| 2018-03-31 | $2.29M 10-Q · filed 2019-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |